News
NICE reverses stance on Celgene’s Revlimid for myeloma maint...
NHS patients in England with newly-diagnosed multiple myeloma can be treated with Celgene’s Revlimid as maintenance therapy after a stem cell transplant, after new guidance from NICE.
